University of Cologne-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2014

  1. Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: Parallel study of 81 patients

    Leukemia and Lymphoma, Vol. 55, Núm. 10, pp. 2341-2348